Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -54.01% is 18% above its 5-year average of -65.68%, near the high end of its 5-year range (-195.04%–0.00%).
33.32% above its 12-month average of -81.00%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -21.49%.
RETURN ON ASSETS (ROA)
-54.01%
RETURN ON ASSETS (ROA) AVG TTM
-81.00%
RETURN ON ASSETS (ROA) AVG 3Y
-93.15%
RETURN ON ASSETS (ROA) AVG 5Y
-65.68%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+33.32%
CURRENT VS 3Y AVG
+42.02%
CURRENT VS 5Y AVG
+17.77%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.12%
median of 605 covered companies
CURRENT VS SECTOR MEDIAN
-85.47%
vs the sector median at left
Spectral AI, Inc.
Market Cap
$54.90M
Return on Assets (ROA)
-54.01%
TTM Avg
-81.00%
3Y Avg
-93.15%
5Y Avg
-65.68%
Market Cap
$56.43M
Return on Assets (ROA)
-98.94%
TTM Avg
-57.19%
3Y Avg
-57.75%
5Y Avg
-128.29%
Market Cap
$53.63M
Return on Assets (ROA)
-34.52%
TTM Avg
-27.74%
3Y Avg
-32.72%
5Y Avg
-28.49%
Market Cap
$56.71M
Return on Assets (ROA)
-48.49%
TTM Avg
-50.18%
3Y Avg
-39.97%
5Y Avg
-38.29%
Market Cap
$53.15M
Return on Assets (ROA)
-44.77%
TTM Avg
-25.55%
3Y Avg
-81.14%
5Y Avg
-76.43%
Market Cap
$57.20M
Return on Assets (ROA)
-37.05%
TTM Avg
-34.36%
3Y Avg
-41.63%
5Y Avg
-37.74%
Market Cap
$52.31M
Return on Assets (ROA)
-127.67%
TTM Avg
-99.17%
3Y Avg
-76.90%
5Y Avg
-71.83%
Market Cap
$51.85M
Return on Assets (ROA)
N/A
TTM Avg
-109.69%
3Y Avg
-346.56%
5Y Avg
-277.44%
Market Cap
$51.78M
Return on Assets (ROA)
-162.93%
TTM Avg
-287.06%
3Y Avg
-300.16%
5Y Avg
-220.25%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spectral AI, Inc. (MDAI) | $54.90M | -54.01% | -81.00% | -93.15% | -65.68% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.43M | -98.94% | -57.19% | -57.75% | -128.29% |
| ImageneBio Inc (IMA)vs › | $53.63M | -34.52% | -27.74% | -32.72% | -28.49% |
| Aldeyra The (ALDX)vs › | $56.71M | -48.49% | -50.18% | -39.97% | -38.29% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $53.15M | -44.77% | -25.55% | -81.14% | -76.43% |
| Boundless Bio, Inc. (BOLD)vs › | $57.20M | -37.05% | -34.36% | -41.63% | -37.74% |
| eXoZymes, Inc. (EXOZ)vs › | $52.31M | -127.67% | -99.17% | -76.90% | -71.83% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.85M | N/A | -109.69% | -346.56% | -277.44% |
| Apollomics, Inc. (APLM)vs › | $51.78M | -162.93% | -287.06% | -300.16% | -220.25% |
| MiNK Therapeutics, Inc. (INKT)vs › | $59.76M | -118.15% | -138.13% | -224.99% | -221.92% |
ROA
-54.0%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -35.37% |
| 2024-12-31 | -126.62% |
| 2023-12-31 | -195.04% |
| 2022-12-31 | -15.56% |
| 2021-12-31 | -21.51% |
| 2020-12-31 | 0.00% |
